Illumina Achieves Many Firsts With the NovaSeq Sequencer
Illumina, the leader in genome sequencing has announced its newest model of gene sequencer that costs under a million dollars, and is able to sequence entire...
Clinical studies and the instrumentation behind them, from trial design to the platforms generating the data.
42 articles
Illumina, the leader in genome sequencing has announced its newest model of gene sequencer that costs under a million dollars, and is able to sequence entire...
Centrifuges are the cornerstone of clinical labs to diagnosing diseases, but unfortunately they cost upwards of thousands of dollars and require electricity, making them useless in...
Labcritics visited Xenopat, an innovative company dedicated to the orthotopic implantation of human tumors in mice. This technology allows Xenopat to offer services to companies...
BioViva reported last week that the company’s CEO, Elizabeth Parrish, successfully reversed biological ageing after being treated with the biotech’s therapies. The Seattle-based company confirmed that Parrish...
Founded by one of the founders of Kayak (a popular travel booking site, nothing to do with research), Trialreach has just completed it Series B,...
A team of scientists led by a research group at University College London have developed a super-resolution microscopy method to diagnose a rare bleeding disease. The...
Illumina has signed agreements with Vanderbilt University, University of Colorado at Anschutz Medical Campus, Partners HealthCare, and Montreal Heart Institute to genotype their sample collections. Illumina’s...
Patient Identification Platform (PatientiP), a provider of clinical trial matching technology, has obtained $2 million in a Series A investment round. The company aims to...